Literature DB >> 25601489

Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study.

Tomas Zaremba1, Annette Ross Jakobsen, Mette Søgaard, Anna Margrethe Thøgersen, Martin Berg Johansen, Laerke Bruun Madsen, Sam Riahi.   

Abstract

BACKGROUND: Pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) may develop malfunction during external beam radiotherapy (RT). We aimed to describe clinical practice in PM/ICD patients undergoing RT and to assess the rate and predictors of device malfunctions.
METHODS: We reviewed medical records of all PM/ICD patients undergoing RT at four centers in Western Denmark during 2003-2012. Logistic regression was applied to identify predictors of PM/ICD malfunctions.
RESULTS: Five hundred sixty patients were included. The annual rate of RT courses in PM/ICD patients increased by 199% from 1.45 treatments per 100,000 person-years in 2003 to 4.33 in 2012. Safety measures included supplementary evaluations of PM/ICD (38.3%), reprogramming (1.5%), relocation of the device (3.5%), and application of a magnet to the ICD during RT (10.8%). At device evaluations after the RT (n = 453), malfunctions were detected in 10 (2.5%) PMs and four (6.8%) ICDs. Electrical resets constituted 11 (78.6%) of the malfunctions, and no failures were life-threatening or warranted PM/ICD removal. Factors associated with device malfunctions in logistic regression analysis were beam energy ≥15 MV (odds ratio [OR] 5.73; 95% confidence interval [CI], 1.58-20.76) and location of tumor below the diaphragm (OR 4.31; 95% CI, 1.42-13.12). However, the effect of tumor location declined (OR 2.27; 95% CI, 0.65-7.95) after adjustment for beam energy.
CONCLUSIONS: Although the rate of RT in PM/ICD patients is increasing, the damaging effects of RT on the devices seem to be usually transient. Our data suggest that high beam energy plays the pivotal role in inducing impairments in these devices. ©2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  beam energy; device malfunctions; implantable cardioverter defibrillator; ionizing radiation; pacemaker; radiotherapy

Mesh:

Year:  2015        PMID: 25601489     DOI: 10.1111/pace.12572

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  15 in total

Review 1.  Electrophysiologic Complications in Cancer Patients.

Authors:  Dae Hyun Lee; Sanjay Chandrashekhar; Michael G Fradley
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

2.  Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments.

Authors:  S Sabater; A Montero; T López Fernández; J J González Ferrer; M Arenas
Journal:  Clin Transl Oncol       Date:  2018-05-23       Impact factor: 3.405

3.  Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients.

Authors:  Vincenzo L Malavasi; Giuseppina De Marco; Jacopo F Imberti; Filippo Placentino; Marco Vitolo; Ercole Mazzeo; Gianfranco Cicoria; Edoardo Casali; Vincenzo Turco; Frank Lohr; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2019-12-02       Impact factor: 3.397

4.  A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy.

Authors:  Maria Daniela Falco; Domenico Genovesi; Luciana Caravatta; Clelia Di Carlo; Ekaterina Bliakharskaia; Marianna Appignani; Massimiliano Faustino; Nanda Furia; Enrico Di Girolamo
Journal:  Strahlenther Onkol       Date:  2020-06-19       Impact factor: 3.621

5.  Radiotherapy in patients with cardiac implantable electronic devices: clinical and dosimetric aspects.

Authors:  Giulia Riva; Ombretta Alessandro; Ruggero Spoto; Annamaria Ferrari; Cristina Garibaldi; Federica Cattani; Rosa Luraschi; Elena Rondi; Nicola Colombo; Fulvio Lorenzo Francesco Giovenzana; Carlo Maria Cipolla; Mikolaj Winnicki; Martina Persiani; Fabiana Castelluccia; Massimo Sarra Fiore; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-04-17       Impact factor: 3.064

6.  Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline-is the risk of relevant errors overestimated?

Authors:  Felix Steger; Matthias G Hautmann; Christoph Süß; Ute Hubauer; Ekrem Ücer; Lars Maier; Oliver Kölbl; Carsten Jungbauer
Journal:  Strahlenther Onkol       Date:  2019-08-09       Impact factor: 3.621

Review 7.  Management of radiation therapy patients with cardiac defibrillator or pacemaker.

Authors:  Francesca Salerno; Sara Gomellini; Cristina Caruso; Raffaele Barbara; Daniela Musio; Tamara Coppi; Mario Cardinale; Vincenzo Tombolini; Ugo de Paula
Journal:  Radiol Med       Date:  2015-12-26       Impact factor: 3.469

8.  PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy-a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Authors:  Anna Rita Alitto; Silvia Chiesa; Pierfrancesco Franco; Michele Fiore; Lorenza Marino; Paolo Borghetti; Isacco Desideri; Daniela Greto; Alba Fiorentino
Journal:  Radiol Med       Date:  2019-12-12       Impact factor: 3.469

9.  Pacemaker malfunction associated with proton beam therapy: a report of two cases and review of literature-does field-to-generator distance matter?

Authors:  Tomoko Ueyama; Takeshi Arimura; Takashi Ogino; Naoaki Kondo; Ryutaro Higashi; Fumihiko Nakamura; Soichiro Ito; Takashi Yoshiura; Yoshio Hishikawa
Journal:  Oxf Med Case Reports       Date:  2016-08-29

10.  Abdominal implantable cardioverter-defibrillator placement in a patient requiring bilateral chest radiation therapy.

Authors:  Ankur A Karnik; Robert H Helm; Sudarshan B Chatterjee; Kevin M Monahan
Journal:  HeartRhythm Case Rep       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.